NovoCure Ltd (NVCR)
Across 43 earnings reports since Oct 26, 2015, NovoCure Ltd (NVCR) has a clear post-earnings pattern. It moves ±8.44% on average after reporting and finishes higher 46.5% of the time. Its largest post-earnings gain was +28.41% (Jul 23, 2026) and its largest decline was -29.28% (Jul 28, 2016). The next earnings report is predicted for 2026-10-28 (approximate).
Earnings reactions
How NVCR moved on each past earnings report.
Earnings Impact
Total Earnings
43
Avg Abs. Movement
±8.44%
Positive %
46.5%
Negative %
53.5%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Jul 23, 2026 | ☀ PRE | +28.41% | open_in_new |
| Apr 30, 2026 | ☀ PRE | +27.49% | open_in_new |
| Feb 26, 2026 | ☀ PRE | -8.27% | open_in_new |
| Oct 30, 2025 | ☀ PRE | -4.9% | open_in_new |
Earnings Count
43
Total earnings in dataset
Avg Abs. Movement
±8.44%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 10-Q | 20260723 | open_in_new SEC.gov |
| 144 | 20260723 | open_in_new SEC.gov |
| 8-K | 20260723 | open_in_new SEC.gov |
| 4 | 20260701 | open_in_new SEC.gov |
| 4 | 20260701 | open_in_new SEC.gov |
| 4 | 20260701 | open_in_new SEC.gov |
| 4 | 20260701 | open_in_new SEC.gov |
| 8-K | 20260630 | open_in_new SEC.gov |
| 8-K | 20260618 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
Frequently asked about NVCR earnings
When does NovoCure Ltd report earnings next? expand_more
NovoCure Ltd (NVCR)'s next earnings date is approximate for 2026-10-28. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does NVCR stock move after earnings? expand_more
Over 43 reports, NVCR has moved an average of ±8.44% the session after earnings, closing higher 46.5% of the time.
What was NVCR's biggest post-earnings move? expand_more
NVCR's largest post-earnings gain on record was +28.41% on Jul 23, 2026, and its largest decline was -29.28% on Jul 28, 2016.
Where can I find NovoCure Ltd's SEC filings? expand_more
All of NovoCure Ltd's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right